Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuling Chen

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2025
METTL5 promotes fatty acid metabolism by modulating peroxisome to induce hepatocellular carcinoma recurrence after thermal ablationZonglin Xie, Lina Wang, Yifan Wu, et al.
Journal of Clinical and Translational Hepatology|May 19, 2025
Mitochondrial Membrane Potential of CD8<sup>+</sup> T Cells Predicts Bacterial Infection and Rapid Development of Acute-on-chronic Liver Failure in Cirrhotic PatientsXixuan Wang, Shuling Chen, Jing Fan, et al.
Journal of Gastroenterology and Hepatology|February 24, 2025
Single-Cell Transcriptomic Analysis Reveals an Aggressive Basal-Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic CholangiocarcinomaChangyi Liao, Yuting Zhang, Jing Yang, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 1, 2026
Molecular classification identifies aggressive gastrointestinal stromal tumor subtype targetable by PARP inhibitorsYuqi Ding, Xiaoxue Ren, Ye Yang, et al.
Journal of Hepatocellular Carcinoma|November 6, 2024
Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics ModelHaoxiang Wen, Ruiming Liang, Xiaofei Liu, et al.
European Radiology|January 23, 2019
Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imagingShuling Chen, Shiting Feng, Jingwei Wei, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2022
Prediction of microvascular invasion in hepatocellular carcinoma with expert-inspiration and skeleton sharing deep learningHan Xiao, Yuchen Guo, Qian Zhou, et al.
JAMA Oncology|June 20, 2024
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical TrialWenzhe Fan, Bowen Zhu, Shuling Chen, et al.
BMC Cancer|June 27, 2022
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk populationZonglin Xie, Zhenpeng Peng, Yujian Zou, et al.
Journal of the American Academy of Dermatology|March 25, 2026
Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy studyLimin Sun, Chenghong Jiang, Shengmiao Li, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 14, 2025
METTL5 promotes fatty acid metabolism by modulating peroxisome to induce hepatocellular carcinoma recurrence after thermal ablationZonglin Xie, Lina Wang, Yifan Wu, et al.
Journal of Clinical and Translational Hepatology|May 19, 2025
Mitochondrial Membrane Potential of CD8<sup>+</sup> T Cells Predicts Bacterial Infection and Rapid Development of Acute-on-chronic Liver Failure in Cirrhotic PatientsXixuan Wang, Shuling Chen, Jing Fan, et al.
Journal of Gastroenterology and Hepatology|February 24, 2025
Single-Cell Transcriptomic Analysis Reveals an Aggressive Basal-Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic CholangiocarcinomaChangyi Liao, Yuting Zhang, Jing Yang, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 1, 2026
Molecular classification identifies aggressive gastrointestinal stromal tumor subtype targetable by PARP inhibitorsYuqi Ding, Xiaoxue Ren, Ye Yang, et al.
Journal of Hepatocellular Carcinoma|November 6, 2024
Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics ModelHaoxiang Wen, Ruiming Liang, Xiaofei Liu, et al.
European Radiology|January 23, 2019
Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imagingShuling Chen, Shiting Feng, Jingwei Wei, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 23, 2022
Prediction of microvascular invasion in hepatocellular carcinoma with expert-inspiration and skeleton sharing deep learningHan Xiao, Yuchen Guo, Qian Zhou, et al.
JAMA Oncology|June 20, 2024
Survival in Patients With Recurrent Intermediate-Stage Hepatocellular Carcinoma: Sorafenib Plus TACE vs TACE Alone Randomized Clinical TrialWenzhe Fan, Bowen Zhu, Shuling Chen, et al.
BMC Cancer|June 27, 2022
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk populationZonglin Xie, Zhenpeng Peng, Yujian Zou, et al.
Journal of the American Academy of Dermatology|March 25, 2026
Artificial intelligence for diagnosis and treatment recommendation in infantile hemangioma: A retrospective multicenter diagnostic accuracy studyLimin Sun, Chenghong Jiang, Shengmiao Li, et al.
Pageof 13